Table 3.

Patient factors associated with genetic testing (multivariate analysis)

Model 1; Without clinical variablesModel 2; With clinical variables included
OR (CI)POR (CI)P
SES Variables
 Low income0.73 (0.53–0.99)0.0425a0.78 (0.57–1.08)0.1335
 High-poverty location0.84 (0.64–1.1)0.21460.82 (0.62–1.08)0.1553
Demographic and clinical characteristics
 Female1.13 (0.88–1.46)0.34081.14 (0.88–1.48)0.3275
 Black (vs. white)1.20 (0.47–3.1)0.70121.16 (0.43–3.14)0.7639
 Asian (vs. white)0.96 (0.35–2.64)0.94220.95 (0.34–2.62)0.9161
 Hispanic (vs. white)1.77 (0.36–8.67)0.47951.95 (0.4–9.43)0.407
 Other/unknown (vs. white)0.53 (0.14–2.04)0.35340.50 (0.13–1.96)0.318
 Urban location1.59 (0.96–2.64)0.07061.60 (0.96–2.66)0.0725
 Diagnosis year2.17 (1.82–2.6)<0.0001a2.18 (1.81–2.63)<0.0001a
 Adenocarcinoma1.56 (1.18–2.07)0.0021a
 Under 75 at diagnosis1.55 (1.19–2.01)0.001a
 Charlson index 3+ (vs. 0)0.53 (0.29–0.97)0.0393a
 Charlson index 2 (vs. 0)1.41 (0.82–2.41)0.214
 Charlson index 1 (vs. 0)0.81 (0.51–1.29)0.3857
Diagnosis year interaction variables
 Low income1.01 (0.94–1.09)0.77931.01 (0.93–1.09)0.8961
 High-poverty location1.00 (0.94–1.07)0.89471.02 (0.95–1.09)0.5733
 Female1.00 (0.95–1.07)0.87850.99 (0.93–1.05)0.713
 Black (vs. white)0.82 (0.65–1.04)0.09890.83 (0.65–1.07)0.1464
 Asian (vs. white)1.14 (0.9–1.46)0.27861.14 (0.89–1.45)0.3126
 Hispanic (vs. white)0.82 (0.55–1.23)0.33860.81 (0.55–1.21)0.2998
 Other/unknown (vs. white)1.31 (0.95–1.82)0.09931.31 (0.95–1.82)0.1038
 Urban location0.94 (0.83–1.05)0.28520.94 (0.83–1.05)0.2743
 Adenocarcinoma1.01 (0.94–1.08)0.8285
 Under 75 at diagnosis0.93 (0.88–1)0.0353a
 Charlson index 3+ (vs. 0)1.10 (0.96–1.27)0.1648
 Charlson index 2 (vs. 0)0.90 (0.79–1.02)0.0972
 Charlson index 1 (vs. 0)1.04 (0.93–1.16)0.4995
  • aSignificant at the 0.05 level.